Asset Management One Co. Ltd. boosted its stake in Xylem Inc. (NYSE:XYL – Free Report) by 4.4% during the second quarter, Holdings Channel.com reports. The firm owned 170,154 shares of the industrial products company’s stock after buying an additional 7,095 shares during the period. Asset Management One Co. Ltd.’s holdings in Xylem were worth $22,011,000 at the end of the most recent quarter.
A number of other large investors have also bought and sold shares of the stock. Vanguard Group Inc. increased its stake in Xylem by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 29,006,544 shares of the industrial products company’s stock worth $3,465,122,000 after purchasing an additional 362,127 shares during the period. Swedbank AB grew its position in shares of Xylem by 13.9% in the 2nd quarter. Swedbank AB now owns 4,366,932 shares of the industrial products company’s stock worth $564,906,000 after buying an additional 531,890 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of Xylem by 7.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,024,500 shares of the industrial products company’s stock worth $480,767,000 after buying an additional 274,123 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of Xylem by 689.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company’s stock worth $443,074,000 after buying an additional 3,239,203 shares during the last quarter. Finally, Northern Trust Corp grew its position in shares of Xylem by 2.9% in the 1st quarter. Northern Trust Corp now owns 3,362,993 shares of the industrial products company’s stock worth $401,743,000 after buying an additional 94,560 shares during the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.
Xylem Trading Up 0.4%
NYSE XYL opened at $148.31 on Friday. The company has a quick ratio of 1.43, a current ratio of 1.90 and a debt-to-equity ratio of 0.17. Xylem Inc. has a twelve month low of $100.47 and a twelve month high of $151.16. The firm has a market capitalization of $36.10 billion, a PE ratio of 38.52, a P/E/G ratio of 2.53 and a beta of 1.13. The stock’s 50 day moving average is $143.79 and its 200 day moving average is $132.76.
Xylem Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th were issued a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend was Thursday, August 28th. Xylem’s payout ratio is 41.56%.
Insider Buying and Selling
In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the business’s stock in a transaction on Friday, September 5th. The stock was sold at an average price of $139.96, for a total value of $139,960.00. Following the sale, the chief accounting officer directly owned 2,957 shares of the company’s stock, valued at approximately $413,861.72. The trade was a 25.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 0.27% of the company’s stock.
Wall Street Analyst Weigh In
XYL has been the topic of a number of recent analyst reports. Zacks Research upgraded Xylem from a “hold” rating to a “strong-buy” rating in a research report on Monday, September 22nd. Stifel Nicolaus lifted their price objective on Xylem from $162.00 to $175.00 and gave the stock a “buy” rating in a research report on Friday, August 1st. Barclays initiated coverage on Xylem in a research report on Friday, September 19th. They issued an “overweight” rating and a $165.00 price objective on the stock. Citigroup lifted their price objective on Xylem from $168.00 to $173.00 and gave the stock a “buy” rating in a research report on Thursday, October 9th. Finally, Mizuho lifted their price target on Xylem from $125.00 to $140.00 and gave the company a “neutral” rating in a research report on Friday, September 12th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $154.67.
View Our Latest Stock Analysis on XYL
Xylem Profile
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Featured Articles
- Five stocks we like better than Xylem
- 3 Warren Buffett Stocks to Buy Now
- Tractor Supply Stock Looks Like a Buy-and-Hold Winner
- The Significance of Brokerage Rankings in Stock Selection
- 3 Stocks Well Below 52-Week Highs Poised for a Q4 Rebound
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Big Banks Are Setting the Tone as Earnings Season Kicks Off
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
